Y-Intercept (HK)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.3M | Buy |
34,874
+25,170
| +259% | +$13.2M | 0.45% | 12 |
|
|
2025
Q1 | $6.15M | Sell |
9,704
-1,821
| -16% | -$1.15M | 0.42% | 37 |
|
|
2024
Q4 | $8.21M | Buy |
11,525
+2,100
| +22% | +$1.5M | 0.55% | 12 |
|
|
2024
Q3 | $9.91M | Buy |
+9,425
| New | +$9.91M | 0.61% | 12 |
|
|
2024
Q2 | – | Sell |
-1,967
| Closed | -$1.89M | – | 1834 |
|
|
2024
Q1 | $1.89M | Sell |
1,967
-1,218
| -38% | -$1.17M | 0.14% | 181 |
|
|
2023
Q4 | $2.8M | Buy |
+3,185
| New | +$2.8M | 0.26% | 75 |
|
|
2023
Q3 | – | Sell |
-2,221
| Closed | -$1.6M | – | 1500 |
|
|
2023
Q2 | $1.6M | Buy |
+2,221
| New | +$1.6M | 0.17% | 151 |
|
|
2023
Q1 | – | Sell |
-1,107
| Closed | -$799K | – | 1474 |
|
|
2022
Q4 | $799K | Buy |
+1,107
| New | +$799K | 0.12% | 267 |
|
|
2022
Q3 | – | Sell |
-847
| Closed | -$501K | – | 1220 |
|
|
2022
Q2 | $501K | Sell |
847
-1,010
| -54% | -$597K | 0.07% | 426 |
|
|
2022
Q1 | $1.3M | Buy |
+1,857
| New | +$1.3M | 0.3% | 71 |
|
|
2021
Q4 | – | Sell |
-4,133
| Closed | -$2.5M | – | 832 |
|
|
2021
Q3 | $2.5M | Sell |
4,133
-73
| -2% | -$44.2K | 0.45% | 33 |
|
|
2021
Q2 | $2.35M | Buy |
+4,206
| New | +$2.35M | 0.6% | 16 |
|